According to Oryzon Genomics's latest financial reports the company has C$0.12 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $C$0.11 B | 13.51% |
2022-12-31 | $C$0.10 B | 2.7% |
2021-12-31 | $C$0.10 B | -13.63% |
2020-12-31 | $C$0.11 B | 33.15% |
2019-12-31 | $C$89.43 M | 27.18% |
2018-12-31 | $C$70.32 M | 35.39% |
2017-12-31 | $C$51.94 M | 61.67% |
2016-12-31 | $C$32.12 M | -23.23% |
2015-12-31 | $C$41.85 M | 113.44% |
2014-12-31 | $C$19.6 M |